Log-in
Sign-up
Webcast
Clinical Trials
Webcast
Clinical Trials
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Completed
NCT00357968
Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous Coronary Intervention With Stenting
201
Enrollment(s)
16
Study location(s)
Interventional (Phase II)
Coronary Artery Disease
Completed
NCT01109784
Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Post Percutaneous Coronary Intervention (PCI).
70
Enrollment(s)
1
Study location(s)
Interventional (Phase III)
Coronary Artery Disease (CAD)
Acute Coronary Syndrome (ACS)
Completed
NCT00654745
18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics
207
Enrollment(s)
0
Study location(s)
Interventional (Phase IV)
Type 2 Diabetes
Hypertension
Unknown status
NCT01158846
Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI
800
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
ST-Elevation Myocardial Infarction
Primary Percutaneous Coronary Intervention
모집 중
KCT0000012
무통 주사를 사용하는 갑상선절제술 후 palonosetron 이 오심 및 구토에 미치는 영향(ondansetron 및 ramosetron과의 비교)
150
Enrollment(s)
1
Study location(s)
중재연구 (해당사항없음)
Completed
NCT00759551
Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension
555
Enrollment(s)
0
Study location(s)
Interventional (Phase II)
Hypertension
Completed
NCT01146106
Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fasting Conditions
43
Enrollment(s)
0
Study location(s)
Interventional (Phase I)
Healthy
Completed
NCT00059215
A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)
905
Enrollment(s)
2
Study location(s)
Interventional (Phase II)
Cardiovascular Diseases
Heart Diseases
101
102
103
104
105